Evaluation of the anticoagulant effect of vitamin K antagonists in patients with non-valvular atrial fibrilation

Evaluation of the anticoagulant effect of vitamin K antagonists in patients with non-valvular atrial fibrilation

Background/Aim. Despite the introduction of new oral anticoagulants (dabigatran, rivoroxaban, apixaban), vitamin K antagonists (VKA), such as warfarin and acenocoumarol are still the most widely used oral anticoagulants for the treatment of nonvalvular atrial fibrillation (NVAF). The time in therape...

Full description

Bibliographic Details
Main Authors: Stanojković Zoran, Antić Ana, Balint Bela, Todorović Milena, Vučić Miodrag, Vacić Nebojša, Lazarević Milan
Format: Article
Language:English
Published: Military Health Department, Ministry of Defance, Serbia 2020-01-01
Series:Vojnosanitetski Pregled
Subjects:
anticoagulants
atrial fibrillation
blood coagulation tests
dose-response relationship, drug
vitamin k
Online Access:http://www.doiserbia.nb.rs/img/doi/0042-8450/2020/0042-84501900008S.pdf

Internet

http://www.doiserbia.nb.rs/img/doi/0042-8450/2020/0042-84501900008S.pdf

Similar Items